Last updated on May 2019

Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Irritable Bowel Syndrome With Constipation | Chronic Constipation
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Constipation (CC) (excluding constipation due to organic diseases) who have used linaclotide for the first time

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.